Consistent with the results, the inhibition of SERPINE1 partially alleviated NAFLD by preventing steatosis events in mice fed with a high-fat, high-cholesterol, high-sugar (HFHS) diet, or a methionine-and choline-deficient (MCD) diet [72]. Here, SERPINE1 is linked to metabolic dysfunction-associated steatotic liver disease.